All Pathways
OtolaryngologyEmergency

Sudden Sensorineural Hearing Loss (AAO-HNSF 2019)

Sudden Sensorineural Hearing Loss (AAO-HNSF 2019): Sudden Hearing Loss Presentation → Distinguish SNHL from Conductive → Urgent Audiometry → Identifiabl...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Sudden Hearing Loss Presentation

    Patient reports acute onset hearing loss. Definition: ≥30dB hearing loss in ≥3 consecutive frequencies occurring within ≤72 hours.

    1. Action

      Distinguish SNHL from Conductive

      KAS 1 (Strong): Perform Weber/Rinne tests. SNHL: Weber lateralizes to GOOD ear, Rinne positive bilaterally. Conductive: Weber to affected ear, Rinne negative affected side.

      • 512 Hz tuning fork preferred
      • Examine ear canal and TM for obstruction/perforation
      • Confirm with audiometry ASAP
      1. Action

        Urgent Audiometry

        Obtain audiogram within 14 days of symptom onset (ideally immediately). Documents degree and configuration of hearing loss. Establishes baseline for monitoring.

        1. Decision

          Identifiable Cause?

          History and exam to exclude: Ototoxic drugs, Meniere's disease, acoustic neuroma, stroke, trauma, infection (otitis, meningitis), autoimmune disease.

          1. Action

            Treat Underlying Cause

            If identifiable cause found: treat accordingly. This algorithm focuses on IDIOPATHIC SSNHL. Stroke protocol if neurological signs.

          2. Decision

            MRI Indicated?

            Consider MRI with gadolinium to evaluate for retrocochlear pathology (acoustic neuroma). Especially if: asymmetric hearing, unilateral tinnitus, focal neurological signs.

            1. Action

              Initial Steroid Therapy

              Offer oral corticosteroids as initial therapy (Option, may offer). Typical: Prednisone 1mg/kg/day (max 60mg) x 10-14 days with taper. OR Dexamethasone 10mg x 7 days. Start within 2 weeks of onset.

              • Benefit decreases with delay
              • Discuss risks: hyperglycemia, insomnia, mood changes
              • No benefit from antivirals (strong against)
              1. Decision

                Response to Initial Therapy?

                Reassess hearing at 2-6 weeks. Complete recovery? Partial recovery? No recovery?

                1. Outcome

                  Hearing Recovered

                  If hearing recovers fully, routine follow-up with audiometry. Counsel on hearing protection. No specific restrictions.

                2. Action

                  Salvage: Intratympanic Steroids

                  KAS: Offer intratympanic steroids 2-6 weeks after symptom onset for incomplete recovery. Dexamethasone 10-24mg/mL or methylprednisolone 40mg/mL. 3-4 injections over 2 weeks.

                  1. Outcome

                    Residual Hearing Loss/Tinnitus

                    KAS 13 (Strong): Counsel on audiologic rehabilitation: hearing aids, CROS/BiCROS, cochlear implant evaluation if profound. Tinnitus management. Support groups.

                3. Action

                  Consider HBOT

                  Hyperbaric oxygen therapy within 2 weeks of onset (in combination with steroids) OR as salvage within 1 month. 10-20 sessions at 2.0-2.5 ATA for 90 minutes.

                4. Action

                  Education & Counseling

                  KAS 7 (Strong): Educate on natural history (1/3 recover, 1/3 partial, 1/3 permanent). Discuss treatment limitations. Address tinnitus if present.

          3. Warning

            ⚠️ DO NOT Order Routinely

            KAS: Do NOT order routine CT head (strong against). Do NOT order routine labs (strong against). Do NOT prescribe antivirals, thrombolytics, vasodilators (strong against).

Guideline Source

AAO-HNSF Clinical Practice Guideline: Sudden Hearing Loss (Update)

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Applies to adults ≥18 years only
  • Does not address pediatric SSNHL
  • Idiopathic SSNHL focus - excludes known causes
  • HBOT availability varies by region

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Sudden Sensorineural Hearing Loss (AAO-HNSF 2019)?

The Sudden Sensorineural Hearing Loss (AAO-HNSF 2019) is a emergency clinical algorithm for Otolaryngology. It provides a structured decision tree to guide clinical decision-making, based on AAO-HNSF Clinical Practice Guideline: Sudden Hearing Loss (Update).

What guideline is the Sudden Sensorineural Hearing Loss (AAO-HNSF 2019) based on?

This algorithm is based on AAO-HNSF Clinical Practice Guideline: Sudden Hearing Loss (Update) (DOI: 10.1177/0194599819859885).

What are the limitations of the Sudden Sensorineural Hearing Loss (AAO-HNSF 2019)?

Known limitations include: Applies to adults ≥18 years only; Does not address pediatric SSNHL; Idiopathic SSNHL focus - excludes known causes; HBOT availability varies by region. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Sudden Sensorineural Hearing Loss (AAO-HNSF 2019) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free